Skip to main content
DNA Labs India

UBE3A Gene Angelman Syndrome NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

UBE3A Gene Angelman Syndrome NGS Genetic Test

Short Name: UBE3A NGS

Also known as: Angelman Syndrome NGS Panel, UBE3A Gene Sequencing, Angelman Syndrome Genetic Test

UBE3A Gene Angelman Syndrome NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks after sample reaches the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic TestAll age groups🏠 Home Collection

🩺 Medically Reviewed By

Overview

To confirm or rule out pathogenic variants in the UBE3A gene in individuals with clinical features of Angelman syndrome; to support a molecular diagnosis, facilitate accurate genetic counselling, and guide management and recurrence-risk assessment.

Test Code
3895
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks after sample reaches the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting required. Please carry any prior genetic reports, neurodevelopmental assessments, and family history documents. A genetic counselling session is recommended before testing to help draw a detailed pedigree chart.

Method: Peripheral venipuncture or FTA card blood spot

Step 2

Laboratory Analysis

Blood sample will be collected by a trained phlebotomist. For FTA card, a few drops of blood are applied to the card and allowed to dry.

Step 3

Report Delivery

No special precautions are needed after sample collection. You may resume normal activities.

Timeline: 3 to 4 weeks after sample reaches the laboratory.

Patient Instructions

1
Before the Test:No fasting is required. A genetic counselling session is recommended to review the family history and to draw a pedigree chart. Please bring all relevant medical records and prior genetic test reports.
2
During the Test:A small blood sample is drawn from the arm. If a FTA card is used, a few drops of blood are collected. The procedure is quick and involves minimal discomfort.
3
After the Test:You can return to routine activities immediately. The laboratory will process the sample and share the report within 3 to 4 weeks.

About This Test

Who Should Get This Test

To confirm or rule out pathogenic variants in the UBE3A gene in individuals with clinical features of Angelman syndrome; to support a molecular diagnosis, facilitate accurate genetic counselling, and guide management and recurrence-risk assessment.

How to Prepare

  • Submit the signed consent form for genetic testing.
  • Provide clinical summary, pedigree chart, and relevant medical records.
  • Ensure the laboratory requisition form matches the patient details exactly.
  • For infants, heel-prick blood spot can be used on FTA card.
  • Store blood sample at room temperature and transport within 48 hours.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Angelman syndrome is a clinical diagnosis supported by genetic testing. A positive UBE3A result can help in counseling the family; however, negative results require a broader genomic approach and close collaboration with a clinical geneticist."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeWhole blood: 1-3 ml; extracted DNA: 5-10 µg; FTA card: one blood spot
ContainerEDTA vacutainer / sterile DNA tube / FTA card
Collection MethodPeripheral venipuncture or FTA card blood spot

Sample Stability

Whole blood in EDTA
Extracted DNA
FTA card blood spot
Sample Rejection Criteria:
  • Haemolysed or clotted blood with insufficient DNA quantity
  • Improperly labelled sample
  • Uninformative consent or no clinical details
  • Sample leaked in transit
  • Old or denatured DNA

Understanding Your Results

This is a targeted genetic test for UBE3A-related Angelman syndrome. Results must be interpreted in the context of clinical presentation, neurodevelopmental findings, EEG data, and other genetic tests.
📊

Pathogenic/likely pathogenic variant in UBE3A

Confirms molecular diagnosis of UBE3A-related Angelman syndrome. Genetic counselling and family screening are recommended.

📊

Variant of uncertain significance (VUS)

Insufficient evidence to classify as benign or pathogenic. Additional family studies or functional analyses may be needed.

📊

No pathogenic variant detected

Does not rule out Angelman syndrome. Methylation-specific PCR, chromosomal microarray, or imprinting centre analysis should be considered if clinical suspicion remains high.

📊

Benign variant only

No diagnostic contribution; clinical correlation still required.

⚠️ When to Consult a Doctor:

If the test is positive, consult a clinical geneticist or neurologist for a comprehensive care plan. If negative but clinical suspicion is high, follow-up testing and multidisciplinary review should be arranged.

Limitations

  • NGS may not reliably detect large deletions, duplications, or methylation changes involving UBE3A
  • Tests may not detect deep intronic variants, large structural rearrangements, or mosaicism
  • A negative result does not exclude Angelman syndrome caused by non-UBE3A mechanisms
  • Results must be interpreted in the context of clinical findings

Risks & Considerations

  • Minor discomfort at venipuncture site
  • Bruising or bleeding
  • Rare risk of infection
  • No significant medical risks associated with genetic testing; however, emotional or psychological stress may occur from result implications

Interfering Factors

  • Contaminated or degraded DNA may lead to sequencing failure
  • Very low DNA concentration
  • PCR inhibitors from haemolysed samples
  • Rare variants in primer or probe binding sites
  • Sample mix-up or mislabelling (pre-analytical)

Compare With Similar Tests

TestUBE3A Gene Angelman Syndrome NGS Genetic TestUBE3A NGS (Current test)Methylation-specific PCRChromosomal Microarray (CMA)FISH
ComparisonUBE3A Gene Angelman Syndrome NGS Genetic Test

Frequently Asked Questions

What is the cost of the UBE3A Gene Angelman Syndrome NGS Genetic Test at DNA Labs India?
The price of this test at DNA Labs India is Rs 20,000. Free home sample collection is available for online bookings.
Which sample is required for the UBE3A NGS test?
Blood or extracted DNA or one drop of blood on an FTA card is accepted. Whole blood should be collected in an EDTA vacutainer.
Do I need to fast before the test?
No, fasting is not required for UBE3A gene NGS testing.
What does this NGS genetic test detect?
The NGS test detects sequence variants, including small insertions and deletions, in the UBE3A gene.
Can NGS detect all causes of Angelman syndrome?
No. NGS does not reliably detect large deletions, chromosomal rearrangements, uniparental disomy, or imprinting defects. Additional tests like methylation-specific PCR and chromosomal microarray may be needed.
How long will the reports take?
Reports are issued within 3 to 4 weeks after the sample reaches the laboratory.
Is home sample collection available?
Yes, free home sample collection is available for online bookings for the UBE3A Gene Angelman Syndrome NGS Genetic Test across India.
Is genetic counselling included with the test?
Yes, the test includes a genetic counselling session to draw a pedigree chart and review the patient's family history before testing.
Will I receive raw data files along with the clinical report?
Yes, DNA Labs India is transparent and will share raw data, FASTQ, and VCF files along with the conclusive clinical report.
What does a negative NGS result mean?
A negative NGS result does not rule out Angelman syndrome. If clinical suspicion remains high, the clinician may recommend methylation-specific PCR or chromosomal microarray.
Who should consider this test?
This test is intended for individuals with clinical features suggestive of Angelman syndrome, including developmental delay, speech impairment, seizures, movement disorder, and happy affect, and for family members of a person with a known UBE3A variant.
Is the test safe for children?
Yes, the test is safe. Only a small blood sample or FTA blood spot is required. Genetic counselling is advised before and after testing.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.